Marty Makary

speaker
939 appearances 6 recordings 5 series first heard Jan 2026 last heard 13 May

Marty Makary’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
4 · Jan OctJan 26AprJulnow

Recordings per month over the last 12 months — 6 in all, peaking in Jan 2026 with 4.

Appearances

newest first · ▶ plays the moment
The approval of OxyContin by the FDA represents one of the moments in FDA's history where it was captured by the industry it was supposed to regulate.
The regulator who approved it for chronic pain, that is long-term use, based on a 14-day study that was presented by the company and then went to work for the company after they left the FDA as a scientific reviewer,
represents that revolving door that we are working so hard to close.
Now, I do think the FDA is in a much better place, but we have to remember that this dark point in our history is emblematic of government regulatory bodies that go through times in their history where they're captured by the same industry they are supposed to regulate.
Another great example of medical dogma was the dogma that natural saturated fat caused heart disease.
As a result of that dogma, the solution was, well, stomp out as much natural fat from people's diets as possible.
Schools went to low-fat milk.
They added sugar.
Nobody cared about sugar.
And a group of scientists the whole time were waving a flag in the air saying, wait a minute, you've got this wrong.
It's refined carbohydrates and added sugar that are driving up inflammation that are creating the insulin resistance that's leading to heart disease and other problems.
But the medical establishment locked arms and walked off a cliff together, declaring natural saturated fat the enemy of public health.
We now know they got it wrong, and we are rewriting the food pyramid at the FDA in order to set the record straight.
We will end the 50-year war on natural saturated fat.
I had largely been apolitical most of my life, but then...
During the first Trump administration, I had been a vocal advocate for price transparency.
That is hospital price transparency, drug price transparency.
The Trump administration was very interested in big ideas, fresh and different ideas on health care.
So I was invited into the White House.
I shared the proposal on hospital price transparency.
Showing 61–80 of 939 · page 4 of 47 ← Previous Next →